Results 91 to 100 of about 383,894 (265)

Association between respiratory syncytial virus activity and pneumococcal disease in infants: a time series analysis of US hospitalization data.

PLoS Medicine, 2015
BackgroundThe importance of bacterial infections following respiratory syncytial virus (RSV) remains unclear. We evaluated whether variations in RSV epidemic timing and magnitude are associated with variations in pneumococcal disease epidemics and ...
Daniel M Weinberger, Keith P Klugman, Claudia A Steiner, Lone Simonsen, Cécile Viboud   +4 more
doaj   +1 more source

Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States

Expert Review of Vaccines, 2019
Introduction: Pneumonia is one of the leading causes of morbidity and mortality among children and older adults. Pneumococcal conjugate vaccines (PCVs) were introduced into the US routine infant vaccination schedule leading to substantial reductions of ...
Andrew D. Wiese, M. Griffin, Carlos G. Grijalva   +2 more
semanticscholar   +1 more source

Pathogenesis and prevention of risk of cardiovascular events in patients with pneumococcal community‐acquired pneumonia

Journal of Internal Medicine, 2019
It is now well recognized that cardiovascular events (CVE) occur quite commonly, both in the acute phase and in the long‐term, in patients with community‐acquired pneumonia (CAP).
C. Feldman, S. Normark, B. Henriques‐Normark, R. Anderson   +3 more
semanticscholar   +1 more source

Serotypes and antibiotic susceptibility of isolated from hospitalized patients with community-acquired pneumonia in Italy

SAGE Open Medicine, 2017
Background: Pneumonia remain an important public health problem. The primary objective was to determine the proportion of community-acquired pneumonia that is attributable to Streptococcus pneumoniae infection; secondary objectives were the description ...
Marta Di Pasquale, Stefano Aliberti, Chara Azzari, Maria Moriondo, Francesco Nieddu, Francesco Blasi, Marco Mantero   +6 more
doaj   +1 more source

Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design

Clinical Infectious Diseases, 2018
Our study demonstrated real-world, direct effectiveness of 13-valent pneumococcal conjugate vaccine against vaccine-type community-acquired pneumonia following introduction into a routine immunization program among adults aged ≥65 years, many of whom had
J. McLaughlin, Q. Jiang, R. Isturiz, H. Sings, D. Swerdlow, B. Gessner, R. Carrico, P. Peyrani, T. Wiemken, William A. Mattingly, J. Ramirez, L. Jodar   +11 more
semanticscholar   +1 more source

Sosialisasi Pneumonia dan Imunisasi PCV (Pneumococcal Conjugate Vaccine) pada Ibu anak Balita di Desa Uevolo Parigi Moutong Sulawesi Tengah

, 2023
Nasrul Nasrul, Fahmi Hafid, Zainul Zainul, Lisnawati Lisnawati, Andi Fatmawati Syamsu, Fajrillah Fajrillah, Selvi Alfrida Mangundap, Niluh Nita Silfia, Sova Evie, Ismunandar Ismunandar, Azizah Saleh, Sigit Muhammad Nuzul, Baharuddin Condeng, Taqwin Taqwin   +13 more
openalex   +2 more sources

Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010–2015

Emerging Infectious Diseases, 2018
Despite use of 7-valent pneumococcal conjugate vaccine, incidence of pleural effusion and empyema (pediatric complicated pneumococcal pneumonia [PCPP]) is reportedly increasing globally.
C. Silva-Costa, M. Brito, M. Pinho, A. Friães, S. Aguiar, M. Ramirez, J. Melo-Cristino   +6 more
semanticscholar   +1 more source

Efficacy of conjugate vaccines in pneumococcal infection prevention

Журнал инфектологии, 2014
The problem of pneumococcal infection is actual for many countries of the world in connection with high incidence and mortality. Vaccination by the 7-valent conjugated pneumococcal vaccine of children till 2 years is available in Russia since 2009, 13 ...
A. L. Perova, A. V. Rudakova, S. M. Kharit   +2 more
doaj   +1 more source

Modular Transcriptional Networks of the Host Pulmonary Response during Early and Late Pneumococcal Pneumonia [PDF]

, 2015
Brendon P. Scicluna, Miriam H. van Lieshout, Dana C. Blok, Sandrine Florquin, Tom van der Poll   +4 more
openalex   +1 more source

Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control

BMC Medicine, 2018
BackgroundThe seven-valent pneumococcal conjugate vaccine (PCV) was introduced in England in September 2006, changing to the 13-valent vaccine in April 2010.
D. Thorrington, N. Andrews, J. Stowe, E. Miller, A. V. van Hoek   +4 more
semanticscholar   +1 more source